| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 9
| Issue : 2 | Page : 55-60 |
|
|
Hereditary hemorrhagic telangiectasia: An informative review
Neha Rajpurohit, Piyush Kumar Bharbey, M Jatin, Khayati Moudgil
Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Tamil Nadu, India
Correspondence Address:
Dr. Khayati Moudgil
Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijh.ijh_24_20
|
|
|
Inherited hemorrhagic telangiectasia (HHT or Osler–Weber–Rendu syndrome) is a hereditary condition characterized by malformations of multiple blood vessels (vascular dysplasia), which may lead to bleeding (hemorrhaging). Chronic nosebleeds are often the first warning, and malformations in various blood vessels can lead to abnormalities in the lungs, brain, spinal cord, and liver. There are a number of therapies available for various aspects of HHT to improve the quality of life and avoid life-threatening complications. Individuals with HHT have an almost average life expectancy. HHT is inherited as a dominant autosomal trait. We have done this review to enlighten the scientific fraternity about HHT. In this review, we have tried to explain about HHT and its related management.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
